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Abstract
Background: Expansion of an unstable (CGG)n repeat to over 200 triplets within the promoter
region of the human FMR1 gene leads to extensive local methylation and transcription silencing,
resulting in the loss of FMRP protein and the development of the clinical features of fragile X
syndrome. The causative link between (CGG)n expansion, methylation and gene silencing is
unknown, although gene silencing is associated with extensive changes to local chromatin
architecture.
Results: In order to determine the direct effects of increased repeat length on gene transcription
in a chromatin context, we have examined the influence of FMR1 (CGG)n  repeats upon
transcription from the HSV thymidine kinase promoter in the Xenopus laevis oocyte. We observe
a reduction in mRNA production directly associated with increasing repeat length, with a 90%
reduction in mRNA production from arrays over 100 repeats in length. Using a kinetic approach,
we show that this transcriptional repression is concomitant with chromatin maturation and, using
in vitro transcription, we show that chromatin formation is a fundamental part of the repressive
pathway mediated by (CGG)n repeats. Using Trichostatin A, a histone deacetylase inhibitor, we
show reactivation of the silenced promoter.
Conclusions: Thus, isolated fragile X associated (CGG)n repeat arrays can exert a modifying and
transcriptionally repressive influence over adjacent promoters and this repressive phenomenon is,
in part, mediated by histone deacetylation.
Background
Expansion of a genetically unstable (CGG)n triplet repeat
was first observed within the promoter region of the hu-
man FMR1 gene in fragile X families (reviewed in refs
[1,2]). In the normal population, the repeat is genetically
stable and ranges from 6 to 54 triplets in length whereas
in fragile X families it ranges from 55 to over several thou-
sands of triplets in length [3]. Expansion to over 200 re-
peats is associated with loss of FMR1 gene transcription
[4], hypermethylation [5–7], late replication [8] and the
expression of a fragile site on the X chromosome. Loss of
the encoded protein, FMRP, results in altered synaptic
maturation (reviewed in ref [9] which leads to develop-
ment of the fragile X syndrome. Similar expansions of
(CGG)n have also been identified at other rare, folate sen-
sitive fragile sites, including those at FRAXE [10], FRAXF
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[11,12], FRA11B [13] and FRA16A [14]. In all cases,
(CGG)n expansion is associated with a length dependent
localised hypermethylation and loss of flanking gene
expression.
An important regulatory mechanism for transcription in
eukaryotes is chromatin architecture (reviewed in
[15,16]). Numerous studies have shown the intimate and
fundamental role of nucleosomal positioning and associ-
ated localised compaction of DNA as a repressive structure
often refractory to transcription factor binding in yeast,
animals and plants (reviewed in [17–19]). In some in-
stances, nucleosomes have been shown to have a role in
transcriptional activation, bringing disparate DNA sites
into juxtaposition and allowing concomitant binding of
activation functions. Chromatin architecture across the
fragile X expansion is consistent with a transcriptionally
silenced state, with the region becoming late replicating
and extensively hypermethylated [5,6,20,21]. In vitro
methylation of the FMR1 promoter region is known to in-
duce transcriptional repression in transient transfection
assays [22,23]. In earlier studies using cloned FMR1 ar-
rays, it was shown that short methylated CGG repeats
have a high affinity for the histone octamer and a highly
positioned nucleosome assembles with the repeat se-
quences positioned at the nucleosomal dyad [24]. This
suggests that the aberrant methylation found at expanded
(CGG)n arrays might target a repressive chromatin struc-
ture to the FMR1 promoter region. Studies on the FMR1
promoter in human cell lines have shown that the repres-
sive phenomenon is linked to hypoacetylated chromatin
[24] and attempts to reactivate silenced FMR1 genes have
had most success with a combination of agents targeting
both methylation and histone acetylation [25].
Nucleosomal architecture is known to be modified
through the action of remodelling machinery; complexes
which are targeted through the modification of select his-
tone tails (reviewed in [26,27]) and specific factor binding
[17]. These can lead to alterations in the functionality of
transcription from a particular promoter. DNA methyla-
tion and hypoacetylation of the local chromatin environ-
ment have been shown to be linked through the action of
MeCP2 an epigenetic transcriptional repressor with affin-
ity for methylated DNA [28]. This protein recruits deacety-
lases through Sin3A to methylated genomic regions
[29,30]. No study to date has examined the influence of
the (CGG)n array in isolation upon transcription.
In this investigation we have studied the effect of increas-
ing (CGG)n repeat length on transcription from a viral
promoter reporter construct after micro-injection into
Xenopus oocytes in order to analyse the contribution of
chromatin to any cis acting effect of the repeats upon tran-
scription. We show that the RNA polymerase II regulated
promoter from the Herpes simplex virus thymidine kinase
gene (HSVtk) becomes transcriptionally repressed when
increasing lengths of (CGG)n are linked in cis. Further-
more, this repression phenomenon is time dependent
and correlates with the formation of chromatin. We show
that the addition of Trichostatin A (TSA) can relieve the re-
peat induced repression. This suggests that the fragile X
(CGG)n associated triplet repeat can direct transcription-
ally repressive chromatin to adjacent promoters and that
local deacetylation of nucleosomes is a major determi-
nant in the repressive pathway.
Results
Reporter plasmid construction
We have developed a model system in which to examine
the transcriptional impact of increasing lengths of fragile
X associated (CGG)n repeats which allows us to investi-
gate the role of chromatin in FMR1 transcriptional repres-
sion. Preliminary experiments with the native human
FMR1 promoter failed to produce sufficient transcription-
al activity in the Xenopus  system (Chandler, Hirst and
Wolffe, data not shown). We therefore utilised a stronger
promoter, the constitutive HSVtk promoter, for subse-
quent studies. A short DNA fragment from the chloram-
phenicol acetyl transferase gene (CAT) was ligated
downstream of the HSVtk promoter to serve as a primer
binding site for primer extension studies. Transcripts de-
tected with this primer represent extended mRNA initiat-
ed at the HSVtk transcription start site but which have not
necessarily been extended through the (CGG)n  array.
Downstream of the CAT primer binding site we inserted
increasing lengths of (CGG)n  repeats. These are posi-
tioned approximately 140 bp downstream from the HS-
Vtk transcription start site, a position similar to that found
in the native human FMR1 promoter [22,42]. All con-
structs prepared were identical apart from the length of
CGG repeat and all were validated to ensure the full
length of the arrays were present. This was done because
we are aware that deletions in these repetitive sequences
can occur and lead to experimental artifacts. Figure 1a
shows a schematic representation of the promoter region
in our reporter construct illustrating the cloning site of the
(CGG)n array. HindIII restriction analysis of reporter con-
structs containing 27, 70 and 105 repeats is shown in Fig-
ure 1b and illustrates the stability of these arrays within
this reporter plasmid.
Increasing (CGG)n repeat length correlates with decreased 
detectable transcript
pHSVtk-CAT plasmid DNA containing increasing num-
bers of (CGG)n repeats was introduced by microinjection
into stage 6 Xenopus laevis oocytes. As shown in Figure
2a, primer extension analysis of 18 hour mRNA pools
shows that increasing repeat length leads to a gradual de-
crease in detectable transcripts. In all cases, we wereBMC Molecular Biology 2003, 4 http://www.biomedcentral.com/1471-2199/4/3
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Figure 1
FMR1 (CGG)n TK-CAT constructs. (a) A schematic representation of the constitutive HSVtk-CAT promoter showing the 
position of the (CGG)n repeat cloning site. The distance from the start site of transcription to the repeats, in base pairs, is sim-
ilar as that found in the native FMR1 promoter. The arrow represents the position of the primer used for the analysis of tran-
scripts by primer extension and the thickened line represents pBR322 vector-derived DNA. (b) An agarose gel showing 
reporter plasmid digests in which HindIII treatment releases the (CGG)n and flanking sequences. Lanes 1, 2 and 3 are digested 
pBR TK-CAT plasmids containing (CGG)27, (CGG)70 and (CGG)105 repeat lengths respectively. The released fragments are 
shown by the arrows corresponding to (CGG)105, (CGG)70 and (CGG)27 respectively. The marker lane contains a 1 kb ladder
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Figure 2
Increased Transcriptional Repression Correlates with Repeat Length. (a) Primer extension analysis of transcripts 
from the HSV-TK promoter adjacent to increased lengths of (CGG)n triplet repeat. None: no injected DNA, CAT: 0.3 ng 
pCMV-CAT alone. All other lanes represent co-injections of 3 ng of reporter DNA and 0.3 ng of control (pCMV-CAT) DNA 
per ooctye. Lane 1: pHSVtk-CAT vector; Lane 2: methylated pHSVtk-CAT vector. Lanes 3 to 6: pHSVtk-CAT containing 27, 
70, 105 and 140 (CGG) triplet repeats, respectively (un-methylated). Post injection, oocytes were incubated for 18 hours at 
18°C. Each extension reaction used RNA from 7 oocytes. (b) A graphical representation of the relative transcription from the 
HSV-TK promoter after normalisation to the co-injected pCMV-CAT control and for background signal. Lane numbers corre-
spond to those in panel A.
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microinjecting equivalent amounts of reporter DNA and
the resultant mRNA levels are standardised against tran-
scripts originating from co-injected pCMV-CAT DNA.
Transcripts from this control plasmid are detected using
the same CAT primer and are distinguished as larger ex-
tension products as seen in Figure 2a. In Figure 2b, it can
be seen that pHSVtk-CAT constructs carrying zero or
(CGG)27 give similar levels of mRNA, suggesting that this
wild-type number of repeats has little effect on transcrip-
tion. As the repeat number is increased to 70 triplets, how-
ever, we see a 25% decrease in transcript levels (Figure 2a
and 2b, lane 4) and upon further increases to 105 and 140
repeats we observe transcript levels drop to less than 10%
of the levels of the wild-type (CGG)27 plasmid (Figure 2a
and 2b, lanes 5 and 6). This modulation of detectable
mRNA levels is not a function of microinjection efficien-
cy, as Southern blot analysis of co-isolated DNA from in-
jected oocytes show no appreciable differences in injected
DNA levels (data not shown). This strongly suggests that
the (CGG)n repeats themselves are responsible for the de-
creased transcription from the HSVtk promoter.
We also note that a reporter containing no repeats and
methylated at all CpG sites was transcriptionally silent in
this assay. This is in agreement with previous studies on
the methylated HSVtk promoter [45]. Hence, a possible
repressive factor in repeat induced silencing might be a de
novo methylation of the reporter construct mediated by
the presence of longer repeats. However a comparative
HpaII/MspI digestion of rescued reporters showed no
methylation at least at HpaII sites (data not shown).
Repression of transcription is concurrent with chromatin 
maturation
Another potential mediator of transcriptional repression
in the Xenopus oocyte is chromatin. To examine the contri-
bution of chromatin to the (CGG)n linked transcriptional
repression, we therefore performed a time course study
where pools of injected oocytes were isolated at various
time points after co-injection, up to 18 hours, the time at
which we observed transcriptional silencing earlier. Re-
sults from this study are shown in Figure 3. As shown in
Figure 3a, control injections with pHSVtk-CAT containing
zero repeats shows that mRNA increases throughout the
18 hour incubation. To standardise for mRNA production
we used a CMV-CAT co-injected control and, as can be see
in Figure 3a, the amount of mRNA from this control grad-
ually increases during the 18 hour incubation. We per-
formed the same study with pHSVtk-CAT-(CGG)70 as this
construct induces transcriptional repression but, as shown
earlier, generates a detectable level of mRNA, even after 18
hours incubation, so allowing us to quantify transcription
levels throughout the time-course of the experiment. The
transcriptional activity of pHSVtk-CAT-(CGG)70 over this
time course can be see in Figure 3a, and is shown graphi-
cally after standardisation to co-injected control DNA in
Figure 3b. As is shown, up to 4 hours post injection, the
two promoters transcribe equivalent amounts of detecta-
ble mRNA. However, after 4 hours there was no further
detectable increase in the amount of mRNA from the
(CGG)70 containing construct. This suggests that by 8
hours, transcriptional repression mediated by the
(CGG)narray has become established.
As we suspected that chromatin assembly was playing a
role in this transcriptional repression, DNA isolated from
the same oocytes injected with pHSVtk-CAT-(CGG)70 and
studied by primer extension above was examined on a gel
containing chloroquine. As one positive supercoil is add-
ed per nucleosome assembled on the reporter DNA [40],
direct visualisation of the supercoiling status of the inject-
ed plasmid DNA can serve as a direct measure of chroma-
tin formation upon injected DNA. As can be seen in Figure
3c, a Southern blot of the chloroquine-containing gel, it is
clear that by 8 hours after injection, chromatin formation
is complete, as judged by the stabilisation of the nucleo-
somal ladder. This mature chromatin formation is con-
comitant with full (CGG)n  mediated transcriptional
repression of the HSVtk promoter as shown in figure 3b.
This strongly suggests that the repression effect associated
with increasing repeat length is causally related to the ex-
tent of chromatin formation upon the reporter. Another
possibility to explain the loss of detectable transcript over
time, is that the mRNA produced from reporters with
longer repeats might have an inherent instability giving
rise to a shorter half life. This seems unlikely as other stud-
ies on native FMR1 transcripts noted no appreciable dif-
ference in mRNA stability over the repeat lengths used in
this study [43].
Transcriptional repression does not occur in the absence of 
chromatin formation
In order to confirm that we were observing a chromatin
mediated effect and to exclude any direct effect of the
(CGG)n repeats upon RNA polymerase II transcription,
we performed an in vitro "run off" transcription reaction
in Hela cell extracts, using primer extension to quantify
the mRNA levels. Although these extracts contain the nec-
essary components for mature chromatin formation, they
are unable to chromatinise the templates during the short
time course of this experiment. Hence any contribution of
chromatin to transcriptional repression is removed. Fig-
ure 4a shows the primer extension products from such an
experiment visualised after separation on a denaturing
polyacrylamide gel. In this experiment, the control CMV-
CAT reporter construct gives a much greater signal com-
pared to the experimental pHSVtk-CAT DNAs. Relative
transcriptional activity of each of the linearised (CGG)n
containing reporter DNA's is shown in Figure 4a and
shown graphically in Figure 4b. As can be seen, equivalentBMC Molecular Biology 2003, 4 http://www.biomedcentral.com/1471-2199/4/3
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Figure 3
Repeat-Induced Transcriptional Repression is Time Dependent. (a) Primer extension products are shown from 
mRNA pools taken from oocytes injected with 5 ng of pHSVtk-CAT (no repeats), or pHSVtk-CAT (CGG70) and with 0.3 ng 
pCMV-CAT as a control for the transcriptional competence of the oocytes. Lane numbers refer to time in hours post-injec-
tion. CON represents no oocyte injection and CAT refers to an injection of 0.3 ng pCMV-CAT alone. Primer extension prod-
ucts corresponding to, CMV-CAT and HSVtk-CAT mRNAs are shown. (b) A graphical representation of levels of transcription 
from the HSV-TK promoter based upon data shown in panel A. Transcription levels are normalised to the co-injected pCMV-
CAT control and for background signal. (c) A Southern blot of a chloroquine supercoiling assay of injected pHSVtk-CAT 
(CGG)70 DNA. Time points of injection mirror those of panel (b). Lane I represents input DNA, other lane numbers refer to 
time in hours post-injection.
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Figure 4
The Role of Chromatin in Repeat Induced Transcriptional Repression (a) Primer extension products are shown from 
run-off RNA transcripts performed in vitro using a Hela cell nuclear extract incubated with pHSVtkCAT, in vitro CpG methyl-
ated pHSVtkCAT, pHSVtkCAT-(CGG)27, pHSVtkCAT-(CGG)70 and pHSVtkCAT-(CGG)105 DNAs. All reactions included 
control of pCMV-CAT DNA. (b) A graphical representation of the detectable transcript in the Helascribe reaction. The tran-
scription was normalised to CMV-CAT as an internal control. (c) Primer extension analysis of the pHSVtkCAT-(CGG)140 
reporter and pCMV-CAT injection control. Injections were of 5 ng reporter and 0.3 ng injection control per oocyte. The 
injected oocyte populations were incubated for 18 hours in the presence of 30 nM TSA. The primer extension products are 
shown with arrows and include the endogenous H4 message as an mRNA preparation control.
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transcriptional activity is exhibited by all reporter con-
structs, regardless of repeat number. Thus, in the absence
of chromatin formation, we see no (CGG)n induced tran-
scriptional repression. This confirms that we only see tran-
scriptional repression after chromatin formation.
Repeat induced transciptional repression is dependant on 
histone deactylases
To examine the nature of the chromatin – mediated re-
pression, we analysed the effect of the global deacetylase
inhibitor TSA on the transcriptional activity of the
CGG140 containing reporter. As can be seen in figure 4c,
in the absence of TSA, the CGG140 mRNA is undetectable,
the band in the correct location on the gel is also present
in the CMV-CAT control lanes, and hence is not reporter
specific. The addition of 30 nM TSA leads to an almost
complete reactivation of the CGG140 reporter to transcrip-
tion levels approaching or surpassing that seen with the
wild type CGG27construct (Fig 2a). These results suggest
an integral role for deacetylation of nucleosomes in the re-
pressive mechanism mediated by isolated CGG repeats.
Discussion
We have shown that (CGG)n lengths in excess of 70 re-
peats can repress transcription from the HSVtk promoter
in Xenopus laevis oocytes. They appear to do so in a length
dependent manner, with arrays over (CGG)105 leading to
over 90% transcriptional repression. We have shown that
this transcriptional repression occurs in a time dependent
manner and is established by eight hours after injection.
Analysis of chromatin formation indicates a correlation
between maximal transcriptional repression and full chro-
matinisation of the injected DNA. Using a HeLa nuclear
extract we show that (CGG)n arrays ranging from 27 to
140 triplets in length do not directly interfere with RNA
polymerase II transcription. This strongly suggests that re-
pression is mediated by the assembly of transcriptionally
repressive chromatin over the HSVtk promoter and that
this is directed by the (CGG)n array, in a length dependent
manner. We show that TSA can relieve the repression as-
sociated with longer repeat length suggesting an integral
role for histone deacteylation in the repressive pathway.
The results of this study are in contrast to the status of
FMR1 gene transcription in fragile X carrier individuals
with (CGG)n arrays between 55 and 200 repeats. In these
individuals, the FMR1 gene is not only transcriptionally
active, but appears to be producing elevated levels of mR-
NA, up to five times the wild type levels of mRNA for the
longer arrays [43,44]. There are several possible explana-
tions for this disparity.
Firstly, it may simply reflect an intrinsic feature of the ex-
perimental system we are using, in that the HSVtk pro-
moter within our construct and within the components
present in the Xenopus oocyte is more sensitive to the re-
pressive effects of the (CGG)n array. As we observe a re-
duction of transcriptional competence of over 90%, this
suggests that the repression mechanism mediated by the
(CGG)n repeat sequence is extremely efficient, capable of
virtually silencing a promoter linked to (CGG)105. The
fact that the HSVtk promoter is highly active compared to
the wild type FMR1 promoter in vivo suggests that this re-
peat induced repressive mechanism would, most likely,
result in complete silencing of the less active FMR1 pro-
moter. Clearly, the ancillary factors required to establish
transcriptional repression are not limiting in the stage six
oocyte nucleus.
A second possibility is the transcriptional repression we
observe might mask any transitory activation. This repres-
sive response may be related to the quantity of injected
DNA used in this study. Although the injection mass is a
typical quantity used, it is the equivalent of a thousand
copies of an identical DNA element. This amount of input
DNA could induce transgene silencing mechanisms which
would mask transient increases in transcript levels, lead-
ing to the establishment of a repressive chromatin envi-
ronment. We do not believe that this type of transgene
silencing is occurring for several reasons. We observe no
repression of either the co-injected control reporter
(CMV-CAT) or with identical amounts of injected pHS-
Vtk-CAT carrying zero or 27 repeats. Previous studies have
shown that methylation effects a time dependent repres-
sion of the HSVtk promoter by inhibition of transcription-
al initiation [45]. If our observations were due to
methylation, we might expect that a concomitant effect of
this process would be de novo CpG methylation of the in-
jected DNA. This does not appear to occur with our inject-
ed (CGG)n constructs, as assayed by comparison between
HpaII/MspI restriction digestions on DNA samples after
microinjection (data not shown). However, we cannot
exclude methylation at a small number of perhaps crucial
CpG sites within the HSVtk promoter not detectable by
methylation sensitive enzyme cleavage reactions we
performed.
We believe that the most likely explanation for the differ-
ence between our observations and those of the intrinsic
FMR1 promoter lies in the isolation of the (CGG)n array
away from its native promoter context. We suggest that the
level of transcriptional activity of the FMR1 promoter is
determined by a balance between the binding of cis-acting
positive transcription factors and the cis-acting repressive
effect of the (CGG)n array. Thus, in our experimental sys-
tem, by isolating the (CGG)n repeat from the normal
FMR1 chromosomal milieu, we may have removed re-
gions of the promoter which serve to counteract the estab-
lishment of a repressive chromatin environment. The
FMR1 promoter contains many such transcription factorBMC Molecular Biology 2003, 4 http://www.biomedcentral.com/1471-2199/4/3
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binding sites, including Sp1, a-Pal/NRF1, AP2, Myc, Zeste,
USF1, USF2 and UBP1 [42,46] whereas the (CGG)n array
itself is not essential for transcription [47].
This transcriptional repression effect of the (CGG)n may
in itself serve as a functional cue for the de novo methyla-
tion across the repeats and the adjacent promoter. In fig-
ure 2, we show that the HSVtk promoter is sensitive to
methylation at CpG sites. Several of the transcription fac-
tors which bind to the FMR1 promoter, including AP2
and α-Pal/Nrf-1, are known to be directly inhibited by
methylation of cytosine residues within their recognition
sites [50,51] and in the fully methylated state, these pro-
teins are absent from the promoter [42,52]. Therefore,
methylation of CpG residues within the FMR1 promoter
would be expected to lead to the loss of transcriptional ac-
tivation. Methylation is known to play an important reg-
ulatory role of the FMR1 promoter and differing degrees
of promoter and repeat methylation are clearly associated
with correspondingly amounts of FMR1 mRNA in devel-
opment [4] and in cases of variability of clinical disease
[53–55]. In addition to the direct effect upon transcrip-
tion activator binding, the experiments of Godde et al
(1996) showed that methylated (CGG)n arrays have a
higher affinity for nucleosomes, indicating that methyla-
tion would also exert a direct effect upon local chromatin
architecture [24]. Experiments are now underway to ana-
lyse the promoter region of injected DNA in more detail
using bisulphite sequencing to determine if the formation
of repressive chromatin can induce local DNA
methylation.
We show an activation of transcription from the silenced
CGG140 reporter by TSA, a broad spectrum deacetylase in-
hibitor. This ability of TSA to relieve repression has also
been shown for the endogenous FMR1 promoter [25,63]
albeit only partially, requiring interference with DNA
methyltransferase for a full effect. We observe a complete
derepression with TSA alone suggesting that upon our re-
porter constructs, which initially carry no methylation,
the major determinant of the repressive effect we observe
is histone deacetylation. The effect of TSA on viral reporter
constructs is well documented [64,65], leading to a multi-
fold activation in all cases. The important result here is
that a previously silenced construct can express when
deacetylase inhibitor is present. This would suggest that
the first stage in FMR1 promoter silencing is mediated
through histone deacetylation, with full and stable repres-
sion being 'locked – in' by methylation at a later stage.
In our suggestion that (CGG)n arrays can act as focus of re-
pressive chromatin structures, is there any evidence for
cellular factors which might mediate such a response?
One potential mediator of a transcriptional effect may be
the protein p20 which has been shown to bind the un-
methylated (but not methylated) FMR1 (CGG)n repeat ar-
ray [56,57]. In transfection studies, expression of this pro-
tein leads to diminished expression from an FMR1
promoter carrying a (CGG)16 repeat array [58]. This, or a
similar protein in Xenopus, might bind to the injected
(CGG)n containing transgenes and mediate or modulate
the assembly of chromatin. In the case of the fragile X syn-
drome, we suggest that the balance between positively act-
ing promoter factors and the repressive (CGG)n  effect
becomes altered when the arrays reaches over 200 repeats.
This could be due to developmentally linked decreases in
the level of transcriptional activators or could be related to
the genetic instability of the array itself. It is possible that
replication or transcription through the array could in-
duce unusual structures within the (CGG)n array which
act as substrates for methyltransferases with associated
deacetylase activity [59,60] or direct altered chromatin
components, such as histone H2AX, as part of the repair
process [61,62]. At this point, the balance between the
two regulatory forces would be then tipped in favour of
the repressive chromatin effect. We have seen that (CGG)n
transcriptional repression can act upon the strong HSVtk
promoter to abolish 90% of transcription, even at 105 re-
peats. Thus, one might predict that in arrays of over 200
repeats the silencing effect would be absolute, the inhibi-
tion of transcription becoming stabilised through rapid
alterations in local chromatin architecture.
Conclusions
Here we have shown that the role of chromatin is funda-
mental to the repression mediated by expanded fragile X
repeats. We have devised an animal system in which we
have isolated the transcriptionally repressive nature of the
(CGG)n array, have shown that chromatin components
are crucial to the process and that deacetylation has a
major role in the repressive effect. The loss of the balance
between this transcriptional repression and normal FMR1
promoter action most likely underlies the gene silencing
seen in fragile X syndrome. This animal model will, there-
fore, prove a valuable tool in the analysis of therapies di-
rected at reactivation of the silenced FMR1 gene. With this
in mind, therapeutic avenues might in future explore the
targeting and modification of the chromatin architecture
in an effort to reactivate the silenced allele in the disease
state before the establishment of a locked-down methylat-
ed FMR1 promoter.
Methods
Reporter plasmid construction
A reporter plasmid, pHSVtk-CAT, was constructed to al-
low stable propagation of human FMR1 (CGG)n arrays by
the introduction of a 330 bp fragment from pBS-TK-CAT
into the EcoRI site of pBR322. This fragment contains the
150 bp BamHI/BglII fragment from the HSV thymidine ki-
nase gene promoter described by McKnight et al [31], aBMC Molecular Biology 2003, 4 http://www.biomedcentral.com/1471-2199/4/3
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short section of pBS derived polylinker and the 5' 30 bp
from the CAT open reading from (ORF). The orientation
of this fragment in pBR322 was determined by the obser-
vation that (CGG)n arrays can be stably propagated only
in one replicative orientation [32]. Human FMR1 (CGG)n
arrays of varying lengths were subsequently introduced
immediately 3' to the CAT ORF by insertion of HinpI frag-
ments into the pBR322 the ClaI site. HinpI digestion re-
moved all flanking human FMR1 genomic DNA. FMR1
(CGG)27 and (CGG)70 HinpI cassettes were isolated di-
rectly from the cloned arrays described by Hirst and White
[32]. The FMR1 (CGG)105 cassette was isolated by plas-
mid rescue from an in vivo expansion event in S. cerevisiae
described in [33]. FMR1 (CGG)140 was made by the con-
catenation of two (CGG)70 HinpI arrays. All constructs
were validated using sequencing and diagnostic restric-
tion analysis as described [33,34] and only plasmid DNA
carrying full length arrays was utilised for further studies.
Plasmid DNA was isolated using Qiagen reagents and re-
precipitated before injection.
The methylated pHSVtk-CAT construct was prepared us-
ing SssI CpG methylase (New England Biolabs) using the
manufacturers protocol. The extent of methylation was
tested using HpaII/MspI comparative digestion.
Preparation, microinjection, and maintenance of oocytes
Stage VI X. laevis oocytes were prepared as described pre-
viously [35]. For each experimental sample, 25–30
healthy oocytes were with 0.3–0.5 ng DNA reporter con-
struct (see figure legend for specific amount) in 13.8 nl of
double distilled water using a Nanoject II apparatus
(Drummond Scientific, PA) and cultured in MBSH buffer
[36] for 0–18 hrs. at 18°C. Specific details of each experi-
ment can be found in the relevant figure legend.
Preparation of mRNA and Primer Extension Analysis
Total RNA was extracted from 7 oocytes per experimental
group as previously described [37], with modifications as
previously outlined [38]. Briefly, oocyte pools were ho-
mogenised in 70 µl 0.25 M Tris-HCl pH7.5 and subse-
quently mixed with 500 µl RNAzol B (Tel-Test,
Friendswood, TX). After the addition of 50-µl chloroform,
a 15 minute incubation on ice and centrifugation at
14,000 rpm for 15 minutes, the aqueous phase was re-
moved and the RNA precipitated with an equal volume of
isopropanol and microcentrifugation. The resultant pellet
was resuspended in 100 µl DEPC water and the RNA re-
precipitated with LiCl. The resultant pellet was resuspend-
ed in 20 µl of DEPC water. 10 µL of this was used for
primer extension analysis.
0.2 pmol of labelled primer specific for the 5' region of the
CAT gene in the reporter constructs was mixed with the to-
tal RNA preparation and annealing performed in 0.6 ×
first strand buffer (Life Technologies, Gaithersberg, MD).
The annealing protocol was: 65°C for 10 minutes, 55°C
for 20 minutes, 37°C for 30 minutes and room tempera-
ture for 5 minutes. 20 U of Superscript II reverse tran-
scriptase were added in conjunction with 2.5 mM dNTP
mixture and 2 U RNase inhibitor (Life Technologies,
Gaithersberg, MD). The reaction was allowed to proceed
for 1 hour at 42°C. The products of the primer extension
were run on an 8% denaturing polyacrylamide gel and vis-
ualised using storage phosphor technology (Molecular
Dynamics). The primer extension experiments in presence
of TSA were performed as above except that the oocytes
were incubated in the presence of 30 nM TSA for 18 hours
prior to harvesting.
All primer extension experiments were performed in trip-
licate to ensure validity and statistical significance.
Analysis of the extent of chromatin formation
30 µl homogenate samples from above, corresponding to
three oocyte equivalents, were mixed with an equal vol-
ume of Proteinase K buffer (30 mM EDTA pH 8.0, 20 mM
Tris-HCl pH 7.5, 1% SDS). 3 µl of 10 mg/ml Proteinase K
was added and the samples incubated for 1 hour at 42°C.
Sample volumes equivalent to 0.5 oocytes were fraction-
ated on a 1% agarose gel in 1 × TPE buffer containing 70
µgm/ml chloroquine as previously described [39,40].
Southern blots of these gels were performed using Bio-
dyne B membrane (Pall, UK) and downward capillary
blotting performed [41]. Probing was carried out exactly
as per manufacturers instructions with Rapidhyb solution
(Amersham Pharmacia Biotech, Little Chalfont, UK) and
high stringency washes.
In Vitro Run Off Transcription analysis
In vitro transcription reactions were performed with 0.5 µg
linearised reporter plasmid DNAs linearised at a single
PvuI site (within the pBR322 vector backbone) and puri-
fied by electrophoresis through 1% agarose. The corre-
sponding bands were excised and electroeluted as
previously described [28]. Transcription reactions were
performed in Helascribe extracts as per manufacturers rec-
ommendations (Promega, UK). The resultant mRNA sam-
ples were analysed for transcript levels using primer
extension as described above.
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